4//SEC Filing
Wigzell Hans Lennart Rudolf 4
Accession 0000950170-24-029536
CIK 0000873303other
Filed
Mar 10, 8:00 PM ET
Accepted
Mar 11, 8:02 PM ET
Size
11.9 KB
Accession
0000950170-24-029536
Insider Transaction Report
Form 4
Wigzell Hans Lennart Rudolf
Director
Transactions
- Sale
Common Stock
2024-03-08$123.85/sh−3,155$390,747→ 34,685 total - Sale
Common Stock
2024-03-08$123.10/sh−11,745$1,445,810→ 22,940 total - Exercise/Conversion
Common Stock
2024-03-08$13.90/sh+15,000$208,500→ 37,840 total - Sale
Common Stock
2024-03-08$122.39/sh−100$12,239→ 22,840 total - Exercise/Conversion
Stock Option (right to buy)
2024-03-08−15,000→ 0 totalExercise: $13.90From: 2016-02-27Exp: 2035-02-27→ Common Stock (15,000 underlying)
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $123.6 to $124.6, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.
- [F2]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $122.65 to $123.58, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.
Documents
Issuer
Sarepta Therapeutics, Inc.
CIK 0000873303
Entity typeother
Related Parties
1- filerCIK 0001492766
Filing Metadata
- Form type
- 4
- Filed
- Mar 10, 8:00 PM ET
- Accepted
- Mar 11, 8:02 PM ET
- Size
- 11.9 KB